Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients

Multimorbidity Clinical Trial

— MULTIPASS-2  

Official title:

Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03697772
• Other study ID #: 2018-A01159-46
• Status: Completed
• Start date: October 15, 2021
• Est. completion date: December 15, 2022

Study information

• Verified date: May 2023
• Source: University of Paris 5 - Rene Descartes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients

Description:

The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date. This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: December 15, 2022
• Est. primary completion date: December 15, 2021
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study

Exclusion Criteria:

• seen at home
• unable to respond (cognitive problems or language barrier)

Related Conditions & MeSH terms

• Continuity of Care
• Multimorbidity

Locations

Country	Name	City	State
France	Université Paris Cité	Paris

Sponsors (1)

Lead Sponsor	Collaborator
University of Paris 5 - Rene Descartes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Continuity of care	Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)	over the past 1year
Primary	care pathway	the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database	over the past 1 year
Secondary	global quality of life	EuroQol Health Questionnaire in 5 questions measuring quality of life by the EuroQol Group. (from 0 to 100, 100= good quality of life)	over the past 1 year
Secondary	burden of traitement	Treatment Burden Questionnaire developped by VT Tran (from 0 to 130, 130 = treatments are a huge problem for the patient)	over the past 1 year